No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Trinity Health Names Mark LePage, M.D., as Senior Vice President of Medical Groups and Ambulatory Strategy

Editor: What To Know

  • He also holds a Master of Business Administration and a Master of Finance from the Kelley School of Business at Indiana University, and completed a Value Measurement for Health Care course at Harvard Business School.
  • Prior to his time at IHA, LePage served as chief medical officer of Marshfield Clinic in Wisconsin, where he led clinical operations of the 700-physician multispecialty medical group.
  • “We look forward to the leadership Mark will bring as Trinity Health continues to advance our medical groups and ambulatory strategy to deliver an exceptional member experience and excellent clinical, operational, and financial outcomes,”.

Trinity Health today announced it has named Mark LePage, M.D., M.B.A., as the new senior vice president, medical groups and ambulatory strategy, effective July 1, 2021. In this position, LePage will take on national responsibility for Trinity Health’s medical groups, leading more than 6,800 physicians and clinicians.

LePage comes to the position after spending four years as the first physician CEO of IHA, Trinity Health’s largest multi-specialty medical group. He is a board-certified vascular and interventional radiologist with a background that spans clinical experience, financial acumen and strategic planning. Under his leadership, IHA successfully expanded into the broader Detroit metro area, acquired a 21-provider primary care group, assumed management oversight over St. Joe’s Medical Group, and worked together with an independent physician organization to develop a Medicare Shared Savings Program.

“We look forward to the leadership Mark will bring as Trinity Health continues to advance our medical groups and ambulatory strategy to deliver an exceptional member experience and excellent clinical, operational, and financial outcomes,” said Trinity Health chief clinical officer Dan Roth, M.D.

Prior to his time at IHA, LePage served as chief medical officer of Marshfield Clinic in Wisconsin, where he led clinical operations of the 700-physician multispecialty medical group. Before his time with Marshfield, he served in the United States Air Force as a Staff Interventional Radiologist at Lackland Air Force Base in Texas.

LePage holds a Bachelor of Science from the University of Michigan and received his medical degree with distinction from the University of Michigan Medical School. He also holds a Master of Business Administration and a Master of Finance from the Kelley School of Business at Indiana University, and completed a Value Measurement for Health Care course at Harvard Business School.

He currently serves on the American Medical Group Association Public Policy Committee, the Board of Trustees for St. Mary Mercy Livonia Hospital, the Ann Arbor SPARK Board of Directors, and the Ann Arbor-Ypsilanti Regional Chamber Board of Directors.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy